Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
CH Biotech R&D Co's 5-Year ROIIC % for the quarter that ended in Dec. 2025 was 97.86%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for CH Biotech R&D Co's 5-Year ROIIC % or its related term are showing as below:
TPE:6534's 5-Year ROIIC % is ranked better than 95.4% of 239
companies
in the Agriculture industry
Industry Median: 3.34
vs TPE:6534: 97.86
CH Biotech R&D Co (TPE:6534) 5-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
CH Biotech R&D Co 5-Year ROIIC % Related Terms
CH Biotech R&D Co 5-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for CH Biotech R&D Co's 5-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6534 vs CTVA, CF, MOS: 5-Year ROIIC % Comparison
For the Agricultural Inputs subindustry, CH Biotech R&D Co's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CH Biotech R&D Co 5-Year ROIIC % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, CH Biotech R&D Co's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where CH Biotech R&D Co's 5-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
CH Biotech R&D Co (TPE:6534) has a 5-Year ROIIC % of 97.86 as of Dec. 2025. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on CH Biotech R&D Co and its competitors. According to the industry distribution chart, CH Biotech R&D Co ranks #11 out of 239 companies in the Agriculture industry, placing it in the top 4.6%.
Is CH Biotech R&D Co's 5-Year ROIIC % too high?
CH Biotech R&D Co's current 5-Year ROIIC % is 97.86. The Agriculture industry median 5-Year ROIIC % is 3.34. CH Biotech R&D Co's value of 97.86 is 2829.9% above this industry median. Based on the distribution chart, CH Biotech R&D Co ranks #11 out of 239 companies in the Agriculture industry, which is in the top quartile — a strong position relative to peers. Overall, CH Biotech R&D Co has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CH Biotech R&D Co's 5-Year ROIIC % compare to CTVA and CF?
According to the Agriculture industry distribution chart, CH Biotech R&D Co ranks #11 out of 239 companies for 5-Year ROIIC %. This places CH Biotech R&D Co in the top 5% of its industry — outperforming the majority of peers. The industry median 5-Year ROIIC % is 3.34. CH Biotech R&D Co's value of 97.86 is 2829.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year ROIIC % for an Agriculture company?
The median 5-Year ROIIC % among Agriculture companies is 3.34, based on 239 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CH Biotech R&D Co's current 5-Year ROIIC % of 97.86 is 2829.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year ROIIC % mean?
A high 5-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on CH Biotech R&D Co and its competitors. For the Agriculture industry, the median 5-Year ROIIC % is 3.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CH Biotech R&D Co's current 5-Year ROIIC % is 97.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CH Biotech R&D Co stock overvalued right now?
Based on GuruFocus' analysis, CH Biotech R&D Co (TPE:6534) is currently considered Fairly Valued. The stock's GF Value™ is NT$100.86, compared to a current price of NT$92.60 — trading 8.2% below its estimated fair value. The current 5-Year ROIIC % is 97.86 and 2829.9% above the Agriculture industry median of 3.34. CH Biotech R&D Co's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year ROIIC % calculated?
5-Year ROIIC % is calculated from a company's financial statements. For CH Biotech R&D Co (TPE:6534), the current 5-Year ROIIC % is 97.86 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CH Biotech R&D Co (TPE:6534) Overvalued in 2026?
Based on GuruFocus' analysis, CH Biotech R&D Co stock appears to be undervalued.
The current stock price of NT$92.60 is trading 8.2% below its estimated GF Value™ of NT$100.86.
GuruFocus considers CH Biotech R&D Co to be Fairly Valued.
Key valuation signals for TPE:6534:
5-Year ROIIC %: 97.86
GF Value™: NT$100.86 vs. price of NT$92.60 (8.2% below fair value)
Industry Position: 2829.9% above the Agriculture median (#11 of 239)
No single metric tells the full story. See the TPE:6534 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CH Biotech R&D Co Ltd is a Taiwan-based company engaged in the manufacture and sales of fertilizer, as well as providing biotechnology services. It is engaged in the research, development, manufacturing, and sales of proprietary plant growth regulators and specialty micronutrient fertilizers. It offers NutriSync 3D plant growers in the form of boron and molybdenum, NutriSync D liquid formulation for dicot crops, CHB-HS for reducing carbon emissions in crop production, CHB-BB2, fruit quality enhancers, and other related products. The company has one reportable segment, Agricultural Biotechnology. Geographically, it derives maximum revenue from the United States, and the rest from other countries.
84GF Score
Get the complete analysis for TPE:6534
5-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6534 has been successfully added to your 
